
Natesto Nasal Gel
Testosterone
- SKU
- 42667-5511
- Mfr
- Acerus Pharmaceuticals Corporation
11 g in 1 applicator, 1 applicator in 1 box
$612.99
Price for one pack
Controlled medicine — prescription required. Upload your prescription at checkout or email it to us after ordering. We ship once a pharmacist has checked it and confirmed it with your prescriber. How it works
1. INDICATIONS AND USAGE Natesto is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.
- Strength
- Testosterone 5.5 mg/.122g
- Unit of measure
- Per .122g
- Dosage form
- Gel, Metered
- Route
- Nasal
Pharmacologic class
- Androgen Receptor AgonistsMechanism
- AndrogenEstablished class
- AndrostanesChemical structure
- Brand name
- Natesto Nasal Gel
- Generic name
- Testosterone
- Manufacturer
- Acerus Pharmaceuticals Corporation
- Product NDC (SKU)
- 42667-5511
- Active ingredients
- Testosterone 5.5 mg/.122g
- Unit of measure
- Per .122g
- Dosage form
- Gel, Metered
- Route
- Nasal
- DEA schedule
- CIII
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application number
- NDA205488
- Marketed since
- May 8, 2020
- Label revised
- July 22, 2025
| Package NDC | Description |
|---|---|
| 42667-5511-1 | 1 APPLICATOR in 1 BOX (42667-5511-1) / 11 g in 1 APPLICATOR |
Reading this NDC
42667-5511-1
- 01Labeler code
- Acerus Pharmaceuticals Corporation
- 02Product code
- Natesto Nasal Gel, gel, metered
- 03Package code
- 1 applicator in 1 box (42667-5511-1) / 11 g in 1 applicator
12.1. Mechanism of Action Endogenous androgens, including testosterone and dihydrotestosterone (DHT), are responsible for the normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. These effects include the growth and maturation of the prostate, seminal vesicles, penis, and scrotum; the development of male hair distribution, such as facial, pubic, chest, and axillary hair; laryngeal enlargement, vocal cord thickening, alterations in body musculature, and fat distribution.
Testosterone and DHT are necessary for the normal development of secondary sex characteristics. Male hypogonadism, a clinical syndrome resulting from insufficient secretion of testosterone, has two main etiologies. Primary hypogonadism is caused by defects of the gonads, such as Klinefelter's syndrome or Leydig cell aplasia, whereas secondary hypogonadism is the failure of the hypothalamus (or pituitary) to produce sufficient gonadotropins (FSH, LH).
1. INDICATIONS AND USAGE Natesto is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone. Primary hypogonadism (congenital or acquired): testicular failure due to conditions such as cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals.
These men usually have low serum testosterone concentrations and gonadotropins (follicle-stimulating hormone [FSH], luteinizing hormone [LH]) above the normal range. Hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation.
These men have low testosterone serum concentrations but have gonadotropins in the normal or low range. Limitations of use: Safety and efficacy of Natesto in men with "age-related hypogonadism" (also referred to as "late-onset hypogonadism") have not been established. Safety and efficacy of Natesto in males less than 18 years old have not been established. Natesto is an androgen indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired)
Hypogonadotropic hypogonadism (congenital or acquired)
Limitations of use. Safety and efficacy of Natesto in men with "age-related hypogonadism" have not been established. Safety and efficacy of Natesto in males less than 18 years old have not been established.
Read before you order

Low testosterone · 2 min read
Low testosterone: symptoms, causes and how it is diagnosed
The symptoms of low testosterone, why diagnosis needs two morning blood tests, and the causes doctors look for.

Low testosterone · 2 min read
Testosterone injections, gels and capsules compared
How testosterone cypionate, enanthate and undecanoate injections compare with gels and oral capsules, and how to choose.

Low testosterone · 2 min read
Testosterone therapy: monitoring, fertility and risks
Why testosterone therapy needs blood tests, how it affects fertility and red blood cells, and the side effects to report.
More in Low Testosterone
View all
Brand · Injection
Aveed
Testosterone Undecanoate 250 mg/mL
- SKU
- 67979-511
- Mfr
- Endo USA, Inc.
From $1,985.31Prescription required

Brand · Injection
Azmiro
Testosterone Cypionate 200 mg/mL
- SKU
- 24338-055
- Mfr
- Azurity Pharmaceuticals, Inc.
From $252.00Min. 2 packsPrescription required

Brand · Capsule
Jatenzo
Testosterone Undecanoate 158 mg/1
- SKU
- 69087-158
- Mfr
- TOLMAR Inc.
From $1,451.99Prescription required

Brand · Capsule
Kyzatrex
Testosterone Undecanoate 150 mg/1
- SKU
- 80603-103
- Mfr
- Marius Pharmaceuticals
From $298.96Min. 2 packsPrescription required